LSDs which are inherited metabolic disorders can be treated with an enzyme replacement therapy (ERT).
biOasis and Shire’s scientists will jointly collaborate to evaluate the potential of Transcend to deliver an enzyme to the brain, as per the agreement,
As part of the mutual agreements, with their own expenses, biOasis and Shire are conducting certain experiments and Shire has been awarded license to biOasis’ Transcend technology.
biOasis Rob Hutchison CEO said the work will start immediately and over the coming months they are looking forward to work with Shire to successfully achieve the objectives set out in the research work plan.